Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, Muranen TA, Barnes DR, Dennis J, Michailidou K, Bolla MK, Leslie G, Aalfs CM; ABCTB Investigators, Adank MA, Adlard J, Agata S, Cadoo K, Agnarsson BA, Ahearn T, Aittomäki K, Ambrosone CB, Andrews L, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, Aronson KJ, Arun BK, Asseryanis E, Auber B, Auvinen P, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Barwell J, Beane Freeman LE, Beauparlant CJ, Beckmann MW, Behrens S, Benitez J, Berger R, Bermisheva M, Blanco AM, Blomqvist C, Bogdanova NV, Bojesen A, Bojesen SE, Bonanni B, Borg A, Brady AF, Brauch H, Brenner H, Brüning T, Burwinkel B, Buys SS, Caldés T, Caliebe A, Caligo MA, Campa D, Campbell IG, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Claes KBM, Clarke CL, Collavoli A, Conner TA, Cox DG, Cybulski C, Czene K, Daly MB, de la Hoya M, Devilee P, Diez O, Ding YC, Dite GS, Ditsch N, Domchek SM, Dorfling CM, Dos-Santos-Silva I, Durda K, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flyger H, Foulkes WD, Friebel TM, Friedman E, Gabrielson M, Gaddam P, Gago-Dominguez M, Gao C, Gapstur SM, Garber J, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA; GEMO Study Collaborators, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Guénel P, Gutierrez-Barrera AM, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hein A, Heyworth J, Hillemanns P, Hollestelle A, Hopper JL, Hosgood HD 3rd, Howell A, Hu C, Hulick PJ, Hunter DJ, Imyanitov EN; KConFab, Isaacs C, Jakimovska M, Jakubowska A, James P, Janavicius R, Janni W, John EM, Jones ME, Jung A, Kaaks R, Karlan BY, Khusnutdinova E, Kitahara CM, Konstantopoulou I, Koutros S, Kraft P, Lambrechts D, Lazaro C, Le Marchand L, Lester J, Lesueur F, Lilyquist J, Loud JT, Lu KH, Luben RN, Lubinski J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martens JWM, Maurer T, Mavroudis D, Mebirouk N, Meindl A, Menon U, Miller A, Montagna M, Nathanson KL, Neuhausen SL, Newman WG, Nguyen-Dumont T, Nielsen FC, Nielsen S, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Olshan AF, Olson JE, Olsson H, Osorio A, Ottini L, Peissel B, Peixoto A, Peto J, Plaseska-Karanfilska D, Pocza T, Presneau N, Pujana MA, Punie K, Rack B, Rantala J, Rashid MU, Rau-Murthy R, Rennert G, Lejbkowicz F, Rhenius V, Romero A, Rookus MA, Ross EA, Rossing M, Rudaitis V, Ruebner M, Saloustros E, Sanden K, Santamariña M, Scheuner MT, Schmutzler RK, Schneider M, Scott C, Senter L, Shah M, Sharma P, Shu XO, Simard J, Singer CF, Sohn C, Soucy P, Southey MC, Spinelli JJ, Steele L, Stoppa-Lyonnet D, Tapper WJ, Teixeira MR, Terry MB, Thomassen M, Thompson J, Thull DL, Tischkowitz M, Tollenaar RAEM, Torres D, Troester MA, Truong T, Tung N, Untch M, Vachon CM, van Rensburg EJ, van Veen EM, Vega A, Viel A, Wappenschmidt B, Weitzel JN, Wendt C, Wieme G, Wolk A, Yang XR, Zheng W, Ziogas A, Zorn KK, Dunning AM, Lush M, Wang Q, McGuffog L, Parsons MT, Pharoah PDP, Fostira F, Toland AE, Andrulis IL, Ramus SJ, Swerdlow AJ, Greene MH, Chung WK, Milne RL, Chenevix-Trench G, Dörk T, Schmidt MK, Easton DF, Radice P, Hahnen E, Antoniou AC, Couch FJ, Nevanlinna H, Surrallés J, Peterlongo P.

NPJ Breast Cancer. 2019 Nov 1;5:38. doi: 10.1038/s41523-019-0127-5. eCollection 2019.

2.

Using digital pathology to understand epithelial characteristics of benign breast disease among women undergoing diagnostic image-guided breast biopsy.

Mullooly M, Puvanesarajah S, Fan S, Pfeiffer RM, Olsson LT, Hada M, Kirk EL, Vacek PM, Weaver DL, Shepherd J, Mahmoudzadeh A, Wang J, Malkov S, Johnson JM, Hewitt SM, Herschorn SD, Sherman ME, Troester MA, Gierach GL.

Cancer Prev Res (Phila). 2019 Oct 23. pii: canprevres.0120.2019. doi: 10.1158/1940-6207.CAPR-19-0120. [Epub ahead of print]

PMID:
31645342
3.

Employment changes following breast cancer diagnosis: the effects of race and place.

Spencer JC, Rotter JS, Eberth JM, Zahnd WE, Vanderpool RC, Ko LK, Davis MM, Troester MA, Olshan AF, Wheeler SB.

J Natl Cancer Inst. 2019 Oct 10. pii: djz197. doi: 10.1093/jnci/djz197. [Epub ahead of print]

PMID:
31599949
4.

Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications.

Allott EH, Shan Y, Chen M, Sun X, Garcia-Recio S, Kirk EL, Olshan AF, Geradts J, Earp HS, Carey LA, Perou CM, Pfeiffer RM, Anderson WF, Troester MA.

Breast Cancer Res Treat. 2019 Sep 18. doi: 10.1007/s10549-019-05442-2. [Epub ahead of print]

PMID:
31535320
5.

A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer.

Barrow MA, Martin ME, Coffey A, Andrews PL, Jones GS, Reaves DK, Parker JS, Troester MA, Fleming JM.

Breast Cancer Res. 2019 Sep 11;21(1):105. doi: 10.1186/s13058-019-1191-3.

6.

Two truncating variants in FANCC and breast cancer risk.

Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, Behrens S, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Burwinkel B, Canzian F, Chan TL, Chang-Claude J, Chanock SJ, Choi JY, Christiansen H, Clarke CL, Couch FJ, Czene K, Daly MB, Dos-Santos-Silva I, Dwek M, Eccles DM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flyger H, Fritschi L, Gabrielson M, Gago-Dominguez M, Gao C, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, Giles GG, Goldberg MS, Goldgar DE, Guénel P, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Hartman M, Hauke J, Hein A, Hillemanns P, Hogervorst FBL, Hooning MJ, Hopper JL, Howell T, Huo D, Ito H, Iwasaki M, Jakubowska A, Janni W, John EM, Jung A, Kaaks R, Kang D, Kapoor PM, Khusnutdinova E, Kim SW, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kwong A, Lambrechts D, Marchand LL, Li J, Lindström S, Linet M, Lo WY, Long J, Lophatananon A, Lubiński J, Manoochehri M, Manoukian S, Margolin S, Martinez E, Matsuo K, Mavroudis D, Meindl A, Menon U, Milne RL, Mohd Taib NA, Muir K, Mulligan AM, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Offit K, Olopade OI, Olshan AF, Olson JE, Olsson H, Park SK, Park-Simon TW, Peto J, Plaseska-Karanfilska D, Pohl-Rescigno E, Presneau N, Rack B, Radice P, Rashid MU, Rennert G, Rennert HS, Romero A, Ruebner M, Saloustros E, Schmidt MK, Schmutzler RK, Schneider MO, Schoemaker MJ, Scott C, Shen CY, Shu XO, Simard J, Slager S, Smichkoska S, Southey MC, Spinelli JJ, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper WJ, Teo SH, Terry MB, Toland AE, Tollenaar RAEM, Torres D, Torres-Mejía G, Troester MA, Truong T, Tsugane S, Untch M, Vachon CM, Ouweland AMWVD, Veen EMV, Vijai J, Wendt C, Wolk A, Yu JC, Zheng W, Ziogas A, Ziv E; ABCTB Investigators; NBCS Collaborators, Dunning AM, Pharoah PDP, Schindler D, Devilee P, Easton DF.

Sci Rep. 2019 Aug 29;9(1):12524. doi: 10.1038/s41598-019-48804-y.

7.

Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study.

Reeder-Hayes KE, Mayer SE, Olshan AF, Wheeler SB, Carey LA, Tse CK, Bell ME, Troester MA.

Cancer. 2019 Nov 15;125(22):3985-3992. doi: 10.1002/cncr.32378. Epub 2019 Aug 9.

PMID:
31398265
8.

Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study.

Benefield HC, Zabor EC, Shan Y, Allott EH, Begg CB, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1784-1791. doi: 10.1158/1055-9965.EPI-19-0365. Epub 2019 Aug 8.

PMID:
31395590
9.

Vascular density of histologically benign breast tissue from women with breast cancer: associations with tissue composition and tumor characteristics.

Fuller AM, Olsson LT, Midkiff BR, Kirk EL, McNaughton KK, Calhoun BC, Troester MA.

Hum Pathol. 2019 Sep;91:43-51. doi: 10.1016/j.humpath.2019.06.003. Epub 2019 Jul 2.

PMID:
31271812
10.

Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.

Puvanesarajah S, Gapstur SM, Patel AV, Sherman ME, Flanders WD, Gansler T, Troester MA, Gaudet MM.

Breast Cancer Res Treat. 2019 Oct;177(3):679-689. doi: 10.1007/s10549-019-05322-9. Epub 2019 Jul 1.

PMID:
31264062
11.

Mortality and cancer incidence among underground uranium miners in the Czech Republic 1977-1992.

Kelly-Reif K, Sandler DP, Shore D, Schubauer-Berigan M, Troester MA, Nylander-French L, Richardson DB.

Occup Environ Med. 2019 Aug;76(8):511-518. doi: 10.1136/oemed-2018-105562. Epub 2019 Jun 5.

PMID:
31167952
12.

Alcohol and DNA Methylation: An Epigenome-Wide Association Study in Blood and Normal Breast Tissue.

Wilson LE, Xu Z, Harlid S, White AJ, Troester MA, Sandler DP, Taylor JA.

Am J Epidemiol. 2019 Jun 1;188(6):1055-1065. doi: 10.1093/aje/kwz032.

PMID:
30938765
13.

Prepregnancy Diabetes and Breastfeeding Cessation Among Black Women in the United States.

Chetwynd EM, Stuebe AM, Rosenberg L, Troester MA, Palmer JR.

Breastfeed Med. 2019 May;14(4):249-255. doi: 10.1089/bfm.2018.0074. Epub 2019 Mar 6.

PMID:
30839228
14.

Hormone therapy use and breast tissue DNA methylation: analysis of epigenome wide data from the normal breast study.

Harlid S, Xu Z, Kirk E, Wilson LE, Troester MA, Taylor JA.

Epigenetics. 2019 Feb;14(2):146-157. doi: 10.1080/15592294.2019.1580111. Epub 2019 Mar 1.

15.

Plasma levels of dichlorodiphenyldichloroethene (DDE) and dichlorodiphenyltrichloroethane (DDT) and survival following breast cancer in the Carolina Breast Cancer Study.

Parada H Jr, Sun X, Tse CK, Engel LS, Olshan AF, Troester MA.

Environ Int. 2019 Apr;125:161-171. doi: 10.1016/j.envint.2019.01.032. Epub 2019 Feb 1.

16.

Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.

Williams LA, Casbas-Hernandez P, Nichols HB, Tse CK, Allott EH, Carey LA, Olshan AF, Troester MA.

PLoS One. 2019 Jan 25;14(1):e0211488. doi: 10.1371/journal.pone.0211488. eCollection 2019.

17.

Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.

Williams LA, Hoadley KA, Nichols HB, Geradts J, Perou CM, Love MI, Olshan AF, Troester MA.

Cancer Causes Control. 2019 Jan;30(1):31-39. doi: 10.1007/s10552-018-1121-1. Epub 2019 Jan 8.

18.

Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.

Heng YJ, Wang J, Ahearn TU, Brown SB, Zhang X, Ambrosone CB, de Andrade VP, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, DuPre NC, Garcia-Closas M, Troester MA, Hunter DJ, Eliassen AH, Tamimi RM, Hankinson SE, Beck AH.

Breast Cancer Res Treat. 2019 Feb;173(3):667-677. doi: 10.1007/s10549-018-5034-1. Epub 2018 Nov 1.

PMID:
30387004
19.

Lifestyle Patterns and Survival Following Breast Cancer in the Carolina Breast Cancer Study.

Parada H Jr, Sun X, Tse CK, Olshan AF, Troester MA.

Epidemiology. 2019 Jan;30(1):83-92. doi: 10.1097/EDE.0000000000000933.

PMID:
30299404
20.

The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Farnan L, Drake BF, Olshan AF, Bensen JT.

Cancer Causes Control. 2018 Nov;29(11):1143-1150. doi: 10.1007/s10552-018-1087-z. Epub 2018 Sep 28.

21.

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype.

Couture HD, Williams LA, Geradts J, Nyante SJ, Butler EN, Marron JS, Perou CM, Troester MA, Niethammer M.

NPJ Breast Cancer. 2018 Sep 3;4:30. doi: 10.1038/s41523-018-0079-1. eCollection 2018.

22.

TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.

Williams LA, Butler EN, Sun X, Allott EH, Cohen SM, Fuller AM, Hoadley KA, Perou CM, Geradts J, Olshan AF, Troester MA.

NPJ Breast Cancer. 2018 Jun 25;4:13. doi: 10.1038/s41523-018-0067-5. eCollection 2018.

23.

Intra-individual Gene Expression Variability of Histologically Normal Breast Tissue.

Sun X, Shan Y, Li Q, Chollet-Hinton L, Kirk EL, Gierach GL, Troester MA.

Sci Rep. 2018 Jun 14;8(1):9137. doi: 10.1038/s41598-018-27505-y.

24.

Genetic ancestry and population differences in levels of inflammatory cytokines in women: Role for evolutionary selection and environmental factors.

Yao S, Hong CC, Ruiz-Narváez EA, Evans SS, Zhu Q, Schaefer BA, Yan L, Coignet MV, Lunetta KL, Sucheston-Campbell LE, Lee K, Bandera EV, Troester MA, Rosenberg L, Palmer JR, Olshan AF, Ambrosone CB.

PLoS Genet. 2018 Jun 7;14(6):e1007368. doi: 10.1371/journal.pgen.1007368. eCollection 2018 Jun.

25.

A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.

Bensen JT, Graff M, Young KL, Sethupathy P, Parker J, Pecot CV, Currin K, Haddad SA, Ruiz-Narváez EA, Haiman CA, Hong CC, Sucheston-Campbell LE, Zhu Q, Liu S, Yao S, Bandera EV, Rosenberg L, Lunetta KL, Ambrosone CB, Palmer JR, Troester MA, Olshan AF.

Breast Cancer Res. 2018 Jun 5;20(1):45. doi: 10.1186/s13058-018-0964-4.

26.

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

Horne HN, Oh H, Sherman ME, Palakal M, Hewitt SM, Schmidt MK, Milne RL, Hardisson D, Benitez J, Blomqvist C, Bolla MK, Brenner H, Chang-Claude J, Cora R, Couch FJ, Cuk K, Devilee P, Easton DF, Eccles DM, Eilber U, Hartikainen JM, Heikkilä P, Holleczek B, Hooning MJ, Jones M, Keeman R, Mannermaa A, Martens JWM, Muranen TA, Nevanlinna H, Olson JE, Orr N, Perez JIA, Pharoah PDP, Ruddy KJ, Saum KU, Schoemaker MJ, Seynaeve C, Sironen R, Smit VTHBM, Swerdlow AJ, Tengström M, Thomas AS, Timmermans AM, Tollenaar RAEM, Troester MA, van Asperen CJ, van Deurzen CHM, Van Leeuwen FF, Van't Veer LJ, García-Closas M, Figueroa JD.

Sci Rep. 2018 Apr 26;8(1):6574. doi: 10.1038/s41598-018-23733-4.

27.

Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.

Kim DJ, Dunleavey JM, Xiao L, Ollila DW, Troester MA, Otey CA, Li W, Barker TH, Dudley AC.

Br J Cancer. 2018 May;118(10):1359-1368. doi: 10.1038/s41416-018-0072-3. Epub 2018 Apr 26.

28.

Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.

Sun X, Stewart DA, Sandhu R, Kirk EL, Pathmasiri WW, McRitchie SL, Clark RF, Troester MA, Sumner SJ.

PLoS One. 2018 Apr 18;13(4):e0193792. doi: 10.1371/journal.pone.0193792. eCollection 2018.

29.

PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.

Puvanesarajah S, Nyante SJ, Kuzmiak CM, Chen M, Tse CK, Sun X, Allott EH, Kirk EL, Carey LA, Perou CM, Olshan AF, Henderson LM, Troester MA.

Cancer Prev Res (Phila). 2018 Jun;11(6):327-336. doi: 10.1158/1940-6207.CAPR-17-0368. Epub 2018 Apr 5.

30.

Associations between Personal Care Product Use Patterns and Breast Cancer Risk among White and Black Women in the Sister Study.

Taylor KW, Troester MA, Herring AH, Engel LS, Nichols HB, Sandler DP, Baird DD.

Environ Health Perspect. 2018 Feb 21;126(2):027011. doi: 10.1289/EHP1480.

31.

Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast.

Chollet-Hinton L, Puvanesarajah S, Sandhu R, Kirk EL, Midkiff BR, Ghosh K, Brandt KR, Scott CG, Gierach GL, Sherman ME, Vachon CM, Troester MA.

Mod Pathol. 2018 Jul;31(7):1085-1096. doi: 10.1038/s41379-018-0033-7. Epub 2018 Feb 20.

32.

Frequency of breast cancer subtypes among African American women in the AMBER consortium.

Allott EH, Geradts J, Cohen SM, Khoury T, Zirpoli GR, Bshara W, Davis W, Omilian A, Nair P, Ondracek RP, Cheng TD, Miller CR, Hwang H, Thorne LB, O'Connor S, Bethea TN, Bell ME, Hu Z, Li Y, Kirk EL, Sun X, Ruiz-Narvaez EA, Perou CM, Palmer JR, Olshan AF, Ambrosone CB, Troester MA.

Breast Cancer Res. 2018 Feb 6;20(1):12. doi: 10.1186/s13058-018-0939-5.

33.

Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.

Parada H Jr, Sun X, Fleming JM, Williams-DeVane CR, Kirk EL, Olsson LT, Perou CM, Olshan AF, Troester MA.

Breast Cancer Res. 2017 Dec 11;19(1):131. doi: 10.1186/s13058-017-0914-6.

34.

Quantification of the Effect of Toxicants on the Intracellular Kinetic Energy and Cross-Sectional Area of Mammary Epithelial Organoids by OCT Fluctuation Spectroscopy.

Yu X, Fuller AM, Blackmon R, Troester MA, Oldenburg AL.

Toxicol Sci. 2018 Mar 1;162(1):234-240. doi: 10.1093/toxsci/kfx245.

35.

Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors.

Butler EN, Bensen JT, Chen M, Conway K, Richardson DB, Sun X, Geradts J, Olshan AF, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):67-74. doi: 10.1158/1055-9965.EPI-17-0404. Epub 2017 Nov 13.

36.

Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.

Williams LA, Nichols HB, Hoadley KA, Tse CK, Geradts J, Bell ME, Perou CM, Love MI, Olshan AF, Troester MA.

Cancer Causes Control. 2018 Jan;29(1):25-32. doi: 10.1007/s10552-017-0977-9. Epub 2017 Nov 9.

37.

Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'.

Reeder-Hayes KE, Troester MA, Meyer AM.

Oncology (Williston Park). 2017 Oct 15;31(10):756-62. Review.

38.

Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.

Chollet-Hinton L, Olshan AF, Nichols HB, Anders CK, Lund JL, Allott EH, Bethea TN, Hong CC, Cohen SM, Khoury T, Zirpoli GR, Borges VF, Rosenberg LA, Bandera EV, Ambrosone CB, Palmer JR, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1722-1729. doi: 10.1158/1055-9965.EPI-17-0450. Epub 2017 Sep 13.

39.

Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.

Troester MA, Sun X, Allott EH, Geradts J, Cohen SM, Tse CK, Kirk EL, Thorne LB, Mathews M, Li Y, Hu Z, Robinson WR, Hoadley KA, Olopade OI, Reeder-Hayes KE, Earp HS, Olshan AF, Carey LA, Perou CM.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx135.

40.

Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study.

Parada H Jr, Sun X, Tse CK, Olshan AF, Troester MA, Conway K.

Cancer Causes Control. 2017 Sep;28(9):929-938. doi: 10.1007/s10552-017-0923-x. Epub 2017 Jul 10.

41.

Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.

DeBono NL, Robinson WR, Lund JL, Tse CK, Moorman PG, Olshan AF, Troester MA.

J Womens Health (Larchmt). 2018 Mar;27(3):377-386. doi: 10.1089/jwh.2016.6063. Epub 2017 Jun 1.

42.

Demographic, lifestyle, and genetic determinants of circulating concentrations of 25-hydroxyvitamin D and vitamin D-binding protein in African American and European American women.

Yao S, Hong CC, Bandera EV, Zhu Q, Liu S, Cheng TD, Zirpoli G, Haddad SA, Lunetta KL, Ruiz-Narvaez EA, McCann SE, Troester MA, Rosenberg L, Palmer JR, Olshan AF, Ambrosone CB.

Am J Clin Nutr. 2017 Jun;105(6):1362-1371. doi: 10.3945/ajcn.116.143248. Epub 2017 Apr 19.

43.

Alcohol Intake and Breast Cancer Risk in African American Women from the AMBER Consortium.

Williams LA, Olshan AF, Hong CC, Bandera EV, Rosenberg L, Cheng TD, Lunetta KL, McCann SE, Poole C, Kolonel LN, Palmer JR, Ambrosone CB, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):787-794. doi: 10.1158/1055-9965.EPI-16-0792. Epub 2017 Apr 18.

44.

Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.

Sun X, Hoadley KA, Kim WY, Furberg H, Olshan AF, Troester MA.

Cancer Causes Control. 2017 Jun;28(6):539-544. doi: 10.1007/s10552-017-0885-z. Epub 2017 Mar 20.

45.

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Hendrix LH, Farnan L, Olshan AF, Bensen JT.

Prostate. 2017 Jun;77(8):878-887. doi: 10.1002/pros.23342. Epub 2017 Mar 6.

46.

Associations among personal care product use patterns and exogenous hormone use in the NIEHS Sister Study.

Taylor KW, Baird DD, Herring AH, Engel LS, Nichols HB, Sandler DP, Troester MA.

J Expo Sci Environ Epidemiol. 2017 Sep;27(5):458-464. doi: 10.1038/jes.2016.82. Epub 2017 Jan 25.

47.

Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.

Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL.

Breast Cancer Res. 2017 Jan 19;19(1):8. doi: 10.1186/s13058-016-0791-4.

48.

Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium.

Ruiz-Narváez EA, Lunetta KL, Hong CC, Haddad S, Yao S, Cheng TD, Bensen JT, Bandera EV, Haiman CA, Troester MA, Ambrosone CB, Rosenberg L, Palmer JR.

NPJ Breast Cancer. 2016;2. pii: 16034. Epub 2016 Oct 26.

49.

Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.

Reaves DK, Hoadley KA, Fagan-Solis KD, Jima DD, Bereman M, Thorpe L, Hicks J, McDonald D, Troester MA, Perou CM, Fleming JM.

Mol Cancer Res. 2017 Feb;15(2):165-178. doi: 10.1158/1541-7786.MCR-16-0085-T. Epub 2016 Nov 17.

50.

Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling.

Taslim C, Weng DY, Brasky TM, Dumitrescu RG, Huang K, Kallakury BV, Krishnan S, Llanos AA, Marian C, McElroy J, Schneider SS, Spear SL, Troester MA, Freudenheim JL, Geyer S, Shields PG.

Oncotarget. 2016 Dec 27;7(52):86457-86468. doi: 10.18632/oncotarget.13241.

Supplemental Content

Loading ...
Support Center